ACCORD Company Profile

✉ Email this page to a colleague

ACCORD has one hundred and fifty-five approved drugs.

There are four US patents protecting ACCORD drugs. There are three tentative approvals on ACCORD drugs.

There are thirty-five patent family members on ACCORD drugs in eighteen countries and three hundred and eighty-seven supplementary protection certificates in eighteen countries.

International Patents:	35
US Patents:	4
Tradenames:	132
Ingredients:	129
NDAs:	155
Patent Litigation for ACCORD:	See patent lawsuits for ACCORD
PTAB Cases with ACCORD as petitioner:	See PTAB cases with ACCORD as petitioner

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Accord Hlthcare	TRAZODONE HYDROCHLORIDE	trazodone hydrochloride	TABLET;ORAL	206923-002	Sep 8, 2017	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Accord Hlthcare	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	206775-003	Feb 9, 2017	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Accord Hlthcare	ZOLEDRONIC ACID	zoledronic acid	INJECTABLE;INTRAVENOUS	205279-001	Nov 28, 2016	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Accord Hlthcare	QUETIAPINE FUMARATE	quetiapine fumarate	TABLET;ORAL	202152-003	Mar 27, 2012	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Accord Hlthcare	DIMETHYL FUMARATE	dimethyl fumarate	CAPSULE, DELAYED RELEASE;ORAL	210499-001	Sep 24, 2020	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01

Subscribe to access the full database, or Subscribe
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2435025	19C1040	France	⤷ Subscribe	PRODUCT NAME: COMBINAISON DE GLYCOPYRROLATE (Y COMPRIS TOUS SELS, ESTERS, ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES DE CELUI-CI) ET DE FORMOTEROL (Y COMPRIS TOUS SELS, ESTERS, ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES DE CELUI-CI); NAT. REGISTRATION NO/DATE: EU/1/18/1339 20181220; FIRST REGISTRATION: - EU/1/18/1339 20181220
1077912	SZ 47/2007	Austria	⤷ Subscribe	PRODUCT NAME: FESOTERODINE UND IHRE SALZE MIT PHYSIOLOGISCH ANNEHMBAREN SAEUREN, EINSCHLIESSLICH FUMARSAEURE
1189916	2/2011	Austria	⤷ Subscribe	PRODUCT NAME: REGADENOSON UND DESSEN SALZE; REGISTRATION NO/DATE: EU/1/10/643/001 20100906
2316456	65/2017	Austria	⤷ Subscribe	PRODUCT NAME: NALTREXON ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, INSBESONDERE NALTREXONHYDROCHLORID, UND BUPROPION ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, INSBESONDERE BUPROPIONHYDROCHLORID; REGISTRATION NO/DATE: EU/1/14/988 (MITTEILUNG) 20150330
0763039	C300348	Netherlands	⤷ Subscribe	PRODUCT NAME: TEMSIROLIMUS, DESGEWENST IN DE VORM VAN EEN; REGISTRATION NO/DATE: EU/1/07/424/001 20071119
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.